Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vascular stenosis refers to the pathological narrowing of blood vessels, most commonly arteries, due to atherosclerosis (plaque buildup of cholesterol, fats, and other substances), leading to restricted blood flow, reduced oxygen and nutrient delivery to tissues, and strain on the cardiovascular system. This condition manifests in specific forms such as carotid artery stenosis (increasing stroke risk), aortic valve stenosis (causing heart strain and potential failure), coronary artery stenosis (leading to ischemia), renal artery stenosis (contributing to hypertension and kidney damage), and peripheral artery stenosis (causing limb pain and ischemia). It arises from risk factors like high cholesterol, hypertension, smoking, diabetes, and aging, progressively worsening if untreated and potentially resulting in severe complications including heart attack, stroke, organ failure, or limb loss. Diagnosis relies on imaging like ultrasound, CT angiography, or MRI to measure stenosis severity (e.g., >50-60% narrowing often prompts intervention). Treatments emphasize lifestyle changes, medical therapy to manage risk factors (statins, antiplatelets), and revascularization procedures such as carotid endarterectomy (CEA), stenting (CAS), or transcarotid artery revascularization (TCAR) for significant blockages. While effective, these interventions carry risks like perioperative stroke or restenosis, with guidelines favoring early action in symptomatic cases. Overall, vascular stenosis underscores the need for cardiovascular risk prevention, as it is not a discrete molecular target but a multifocal disease process amenable to mechanical and conservative management.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular stenosis.